145 related articles for article (PubMed ID: 21499216)
1. RUNX1T1: a novel predictor of liver metastasis in primary pancreatic endocrine neoplasms.
Nasir A; Helm J; Turner L; Chen DT; Strosberg J; Hafez N; Henderson-Jackson EB; Hodul P; Bui MM; Nasir NA; Hakam A; Malafa MP; Yeatman TJ; Coppola D; Kvols LK
Pancreas; 2011 May; 40(4):627-33. PubMed ID: 21499216
[TBL] [Abstract][Full Text] [Related]
2. Met proto-oncogene and insulin-like growth factor binding protein 3 overexpression correlates with metastatic ability in well-differentiated pancreatic endocrine neoplasms.
Hansel DE; Rahman A; House M; Ashfaq R; Berg K; Yeo CJ; Maitra A
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6152-8. PubMed ID: 15448002
[TBL] [Abstract][Full Text] [Related]
3. p21 Protein Outperforms Clinico-pathological Criteria in Predicting Liver Metastases in Pancreatic Endocrine Tumors.
Nasir A; Ahmed MK; Saller JJ; Henderson-Jackson EB; Malafa MP; Yeatman TJ; Coppola D
Cancer Genomics Proteomics; 2023; 20(6):522-530. PubMed ID: 37889062
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of membrane proteins in primary and metastatic gastrointestinal neuroendocrine tumors.
Carr JC; Sherman SK; Wang D; Dahdaleh FS; Bellizzi AM; O'Dorisio MS; O'Dorisio TM; Howe JR
Ann Surg Oncol; 2013 Dec; 20 Suppl 3(0 3):S739-S746. PubMed ID: 24114056
[TBL] [Abstract][Full Text] [Related]
5. EPB41L5 is Associated With the Metastatic Potential of Low-grade Pancreatic Neuroendocrine Tumors.
Saller J; Seydafkan S; Shahid M; Gadara M; Cives M; Eschrich SA; Boulware D; Strosberg JR; Aejaz N; Coppola D
Cancer Genomics Proteomics; 2019; 16(5):309-318. PubMed ID: 31467225
[TBL] [Abstract][Full Text] [Related]
6. Clinically Significant Differences in Ki-67 Proliferation Index Between Primary and Metastases in Resected Pancreatic Neuroendocrine Tumors.
Richards-Taylor S; Tilley C; Jaynes E; Hu H; Armstrong T; Pearce NW; Plant R; Cave J
Pancreas; 2017; 46(10):1354-1358. PubMed ID: 28984786
[TBL] [Abstract][Full Text] [Related]
7. PAX8 Expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors.
Long KB; Srivastava A; Hirsch MS; Hornick JL
Am J Surg Pathol; 2010 May; 34(5):723-9. PubMed ID: 20414099
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets.
Capurso G; Lattimore S; Crnogorac-Jurcevic T; Panzuto F; Milione M; Bhakta V; Campanini N; Swift SM; Bordi C; Delle Fave G; Lemoine NR
Endocr Relat Cancer; 2006 Jun; 13(2):541-58. PubMed ID: 16728581
[TBL] [Abstract][Full Text] [Related]
9. Multiple endocrine neoplasia type 1 associated with a new mutation in the menin gene and a midgut neuroendocrine tumor.
Agarwal R; Szalkiewicz ER; Warner RR; Roayaie S; Hechtman JF; Zhu H; Kim MK
Pancreas; 2014 Jan; 43(1):145-6. PubMed ID: 24326372
[No Abstract] [Full Text] [Related]
10. HSP90 expression and early recurrence in gastroenteropancreatic neuroendocrine tumors: Potential for a novel therapeutic target.
Gamboa AC; Ethun CG; Postlewait LM; Lopez-Aguiar AG; Zhelnin K; Krasinskas A; El-Rayes BF; Russell MC; Kooby DA; Staley CA; Cardona K; Maithel SK
Surg Oncol; 2020 Dec; 35():460-465. PubMed ID: 33080545
[TBL] [Abstract][Full Text] [Related]
11. Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases.
Schmitt AM; Riniker F; Anlauf M; Schmid S; Soltermann A; Moch H; Heitz PU; Klöppel G; Komminoth P; Perren A
Am J Surg Pathol; 2008 Mar; 32(3):420-5. PubMed ID: 18300808
[TBL] [Abstract][Full Text] [Related]
12. Identification of potential therapeutic targets by gene-expression profiling in pancreatic endocrine tumors.
Couvelard A; Hu J; Steers G; O'Toole D; Sauvanet A; Belghiti J; Bedossa P; Gatter K; Ruszniewski P; Pezzella F
Gastroenterology; 2006 Nov; 131(5):1597-610. PubMed ID: 17064702
[TBL] [Abstract][Full Text] [Related]
13. Function and clinical relevance of RHAMM isoforms in pancreatic tumor progression.
Choi S; Wang D; Chen X; Tang LH; Verma A; Chen Z; Kim BJ; Selesner L; Robzyk K; Zhang G; Pang S; Han T; Chan CS; Fahey TJ; Elemento O; Du YN
Mol Cancer; 2019 May; 18(1):92. PubMed ID: 31072393
[TBL] [Abstract][Full Text] [Related]
14. Palladin is a marker of liver metastasis in primary pancreatic endocrine carcinomas.
Henderson-Jackson EB; Helm J; Strosberg J; Nasir NA; Yeatman TJ; Kvols LK; Coppola D; Nasir A
Anticancer Res; 2011 Sep; 31(9):2957-62. PubMed ID: 21868544
[TBL] [Abstract][Full Text] [Related]
15. Decreased UCHL1 expression as a cytologic biomarker for aggressive behavior in pancreatic neuroendocrine tumors.
Moore MD; Finnerty B; Gray KD; Hoda R; Liu YF; Soong L; Beninato T; Rao R; Zarnegar R; Fahey TJ
Surgery; 2018 Jan; 163(1):226-231. PubMed ID: 29150024
[TBL] [Abstract][Full Text] [Related]
16. Differential Protein Expression in Small Intestinal Neuroendocrine Tumors and Liver Metastases.
Kim MK; Ye F; Wang D; Cui M; Ward SC; Warner RR; Roayaie S; Shafir M; Schwartz M; Zhang D; Itzkowitz S
Pancreas; 2016 Apr; 45(4):528-32. PubMed ID: 26474427
[TBL] [Abstract][Full Text] [Related]
17. Loss of succinate dehydrogenase subunit B (SDHB) as a prognostic factor in advanced ileal well-differentiated neuroendocrine tumors.
Milione M; Maisonneuve P; Pellegrinelli A; Pusceddu S; Centonze G; Dominoni F; Brambilla C; Rubino M; Faggiano A; Buzzoni R; Concas L; Giacomelli L; Coppa J; Mazzaferro V; de Braud F
Endocrine; 2017 Sep; 57(3):512-517. PubMed ID: 27905048
[TBL] [Abstract][Full Text] [Related]
18. ALCAM (CD166) expression as novel prognostic biomarker for pancreatic neuroendocrine tumor patients.
Tachezy M; Zander H; Marx AH; Gebauer F; Rawnaq T; Kaifi JT; Sauter G; Izbicki JR; Bockhorn M
J Surg Res; 2011 Oct; 170(2):226-32. PubMed ID: 21816425
[TBL] [Abstract][Full Text] [Related]
19. Differences between Well-Differentiated Neuroendocrine Tumors and Ductal Adenocarcinomas of the Pancreas Assessed by Multi-Omics Profiling.
Starzyńska T; Karczmarski J; Paziewska A; Kulecka M; Kuśnierz K; Żeber-Lubecka N; Ambrożkiewicz F; Mikula M; Kos-Kudła B; Ostrowski J
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32586046
[TBL] [Abstract][Full Text] [Related]
20. Downregulated Pancreatic Beta Cell Genes Indicate Poor Prognosis in Patients With Pancreatic Neuroendocrine Neoplasms.
Kudo A; Akahoshi K; Ito S; Akashi T; Shimada S; Ogura T; Ogawa K; Ono H; Mitsunori Y; Ban D; Tateishi U; Tanaka S; Tanabe M
Ann Surg; 2020 Apr; 271(4):732-739. PubMed ID: 29979246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
